To better understand the cellular target(s) of cyclosporin action in psoriasis, we have studied the effects of syste'mic short-term (7 d), low-dose (3 -7.5 mg/kg) cyclosporin A administration on the expression of the cytokines interleukin (IL) -8 and IL-1 fJ in psoriatic lesions. RNA blot hybridization analysis of pretreatment keratome biopsies revealed. that express ion ofbo~h cyt~ki~e mRNAs v.:as.highly variable fr?m patient to patIent. Slglllficant covanatlOn of both cytokme rnRNA levels was noted (r = 0.86, P < 0.0001). However, there was no significant correlation between expression of either cytokine and clinical severity, as measured by the pretreatment Psoriasis Area and Severity Index (P ASI). IL-1 fJ protein levels measured by enzyme-linked immunosorbent assay (ELISA) were highly correlated with IL-1 fJ mRNA levels, indicating that the differences in transcript levels accurately reflect differences in epidermal cytokine protein.
Signific.ant reductio~s in both cytokine transcripts and in IL-1 (lunmunoreactive protein were noted in the high expr~sslOn subgroup after 1 week of cyclosporin A therapy, pnor to detectable clinical improvement. In contrast to its pronounced effects on epidermal cytokine expression in vivo and ~he allo~eneic mixed lymphocyte reaction in vitro, cyclosponne A dId not inhibit the induction of intercellular ad hesion mol.ecule (ICAM)-l or IL-8 mRNAs by cultured keratinocytes In response to IL-1 fJ or the combination of tumor necrosis factor (TNF)-a and interferon (IFN)-y. These data suggest that .epidermal keratinocytes respond to signals produced by ~ctivated T cells by coordinate expression of multiple cytokmes, and that cyclosporin A acts primarily through b.lockade ofT cells,. rather than through keratinocyte activatIOn. Key words: Immunology/skin disease/interleukins/ ICAM-1/chemokines.j Invest Dermatol1 01 : [761] [762] [763] [764] [765] [766] 1993 necrosis factor (TNF)-Cl', it becomes important to determine ~hether the effec~s of CsA on keratinocyte cytokine production in 111110 are exer~ed dIrectly upon the keratinocyte, or instead reflect a blockade of Immune system activation.
CsA is an effective antipsoriatic agent at both high [1] and low [7] doses, although the rate of clearing is dose dependent. We have taken advantage of this observation to study the effects of shortt~rm CsA tre~tme~lt on cytokine gene expression in keratome biopsIes of psorIatIc sk1l1 prior to detectable clinical improvement. This study had two major objectives: i) to determine whether reduced cytokine expression precedes clinical improvement, thus providing sO. me eVIdence ~or the ~:u-ticipation of epidermal cytokines in psoriaSIs pathogeneSIs, and u) to determine whether the effects of CsA are exert.ed directly ?r indirectly on the psoriatic keratinocyte. To accomphsh these objectives, we performed Northern blot and enzyme-linked. im~unosorbent assay (ELISA) analysis of IL-1 p and IL-8 expressIOn 111 keratome biopsies before and after 1 week of low-dose C~A treatment. In addition, we compared the effects of CsA on psorIatIc leSIons in VitlO to its effects on the induction ofIL-8 and intercellular adhesion molecule (ICAM)-l mRNAs by IL-1, IFN-y, an.d T~F-Cl' in cult~red keratinocytes. The results suggest ~hat a~phficatl?n of cytokme signaling may occur via a pathway 1I1volv1l1g kerat1l10cyte-denved IL-8 in psoriatic lesions ill VitlO. In addition, comparisou of ill VitlO and ill vitro results suggests that CsA exerts one or more indirect effect(s) upon the expression of keratinocyte-derived cytokines in psoriasis, presumably by inhibiting the elaboratIon of actlvat1l1g slgnal(s) by immune and/or inflammatory cells. 
MATERIALS AND METHODS
Study Design and Tissue Procurement The cohort of 26 patients studied here was a subset of the 85 patients enroll ed in a multidose CsA trial conducted at the University of Michigan (7) . Patients received oral CsA at doses of3 mg/kg/d (nine patients), 5 mg/kg/d (12 patients), or 7.5 mg/kg/ d (one patient), or placebo consisting of olive oil and polyoxyethylated oleic glycerides (olive oil Labrafil base, four patients). Prior to and after 7 d of treatment, lesional buttocks or thigh skin was subjected to keratome biopsy at a depth of 0.2-0.4 mm using a Castroviejo keratome. Normal volunteers and psoriatics not treated with CsA were recrUited from the Southeast Michigan area and the Department of Dermatology clinic population and biopsied in an identical fashion. All studies involving human subjects were approved by the Institutional Review Board of the University of Michigan, and informed consent was obtained from each patient.
Cell Culture Primary cu ltures of normal human keratinocytes were prepared as described [9) from keratome biopsies of adult volunteers. Subcultures were expanded in keratinocyte growth medium (KGM; Clonetics, San Diego, CAl, and used in the second to fourth passage. Cells were pretreated for 2-16 h with CsA dissolved in dimethylsulfoxide vehicle (0.1 % final concentration), with triamcinolone acetonide (TAC) dissolved in 10% ethanol vehicl e [10) (0.01 % final ethanol concentration) or with vehicle alone.
The cells were then treated with either IL-l cr. (5-100 ng/ml; Dainippon, Osaka, Japan) or a combination ofTNF-cr. (20 ng/ml; Amgen, Thousand Oaks, CAl and IFN-y (100 U/ml; Collaborative Research, Bedford, MA). Cytokine stocks were prepared in sterile phosphate-buffered saline (PBS) and stored in small aliquots at -70 'C prior to use. After 6 h of cyrokine treatment, cultures were harvested for RNA isolation as described below.
RNA Isolation and Analysis RNA was prepared from snap-frozen keratome biopsies by the guanidinium isothionate-cesium chloride technique as previously described [11) , except that cesium trifluoroacetate (Pharmacia, Piscataway, Nl) was used according to the manufacturer's instructions. RNA was isolated from keratinocytes using RNAzol (Tel-Test, Friendswood, TX) as directed by the manufacturer. Forty micrograms total keratome RNA, or 20 /-Ig total keratinocyte RNA (determined by optical density
[00],60) was electrophoretically separated on 1 % form aldehyde-agarose gels and transferred to derivatized nylon membrane (Zeta-Probe; Bio-Rad, Richmond, CAl. Blots were hybridized against 32P-labe led probes prepared as described below, and were quantitated using either a laser densitometer . [11) or a phosphorimager [12) and normalized to cyclophilin as previously described [11) .
Plasmids and Hybridization Probes Plasmid DNAs were prepared by alkaline lysis and precipitation in polyethylene glycol [13) . cDNA inserts were prepared by digestion with appropriate restriction endonucleases followed by electrophoresis in low-melting-temperature agarose gels. Inserts were 32P-labeled by random priming, and had a specific activity of 1-4 X 10 9 cpm//-Ig DNA. The IL-l p (14) , lipocortin II l11), and cyclophilin (11) probes used in these experiments have been previously described. The IL-8 probe was a 0.45-kilobase pair (kb) Eco Rl insert from the plasmid pMDNCF 2-1 0.5 (15) , the ICAM-l probe was a 1.9-kb XbaI fragment containing the entire ICAM-l coding sequence derived from the plasmid pGICAM-l [16) , and [he cel lular retinoic acid binding protein (CRABP)-Il probe was a 0.9-kb EcoRl fragment derived from a human skin fibroblast library (12) . The 36B4 probe was a 0.7 -kb PstI fragment derived from p36B4 [17) , which has recently been shown to encode the human acidic ribosomal phosphoprotein PO [18) .
Data Analysis All keratome biopsy-derived RNA specimens were blotted and sequentially rehybridized in parallel, allowing the quantitative dara from a total of three blots to be pooled. IL-8, IL-l p, and CRABP-Il densitometry or phosphorimager data were normalized to cyclophil in to control for differences in loading and RNA intactness. Statistical comparisons were made on the normalized data using analysis of variance as previously reported [6J.
ELISA Assay oflL-l cr. and p In a subset of patients, the week 0 and week 1 keratome biopsy specimens were divided, a portion bein g used to prepare RNA and the remainder to assay IL-l immunoreactive protein levels. Aqueous extracts of snap-frozen keratomes were prepared using Dulbecco's PBS containing 0.03% polyethylene glycol, and immunoreactive IL-1 pwas measured using a commercially available kit (Cistron, Pine Brook Nj) as described (14) . Immunoreactive IL-l cr. was quantified using an ELISA composed of monoclonal anti -IL-l cr. and polyclonal rabbit anti -IL-l cr. (both from Dainippon, O saka, japan) as described previously [14) .
Immunocytochemistry Portions of the same frozen keratome biopsies used to prepare RNA were mounted in OCT compound (Miles Diagnos-~ Allogeneic Mixed Leukocyte Reaction (AMLR) Lymphocytes were isolated from peripheral blood of two healthy individuals by Ficoll -Hypaque ce ntrifugation. Ten milliliters of blood were diluted with an equal volume of RPM! 1640 medium and layered over 15 ml ofHistopaque-l077 (Sigma, St . Louis, MO) and centrifuged for 30 min at 500 X g. The lymphocyte band a[ the interphase was coll ected, washed twice, and resuspended in RPM! 1640 containing 10% human AB serum at 5 X 10 6 cells/m!. The two-way mixed lymphocyte reaction was initiated by mixing 100-/-11 aliquots of the cell suspension from each of the two individuals (50,000 ce ll s each) in a roundbottom 96-well plate. The mixed cells were treated with 1 /-II of a 200 X solution of CsA in DMSO, or a 1000 X solution ofTAC in 10% ethanol. 90% sterile water [10) to obtain the desired final co ncentration, or vehicle alone. Triplicate well s were used for eac h concentration of drug. The cells were incubated at 37'C in a humidified incubator under 5% CO 2 , On day 6 the cells in each wel l were treated with 10 /lCi of lH-thymidine and incubated for another 18 h. The ce lls were transferred to filters using a cell harvester and washed with ethanol, and 3H-thymidine incorporation was determined by scintillation counting.
RESULTS
Clinical Evaluation After 1 week of CsA therapy (3-7.5 mg/ kg/d), there was no significant difference in clinical severity relative to baseline, as evidenced by the Psoriasis Area and Severity Index (PAS I) [19] . However, with prolonged therapy, significant clinical improvement w as seen in this co h ort of patients by 2 weeks (Fig 1, closed circles). In contrast, no improvement was obtained in the placebo group at any time point (Fig 1, open circles) .
Heterogeneity of Cytokine Expression In Vivo Figure 2 previously [11] and are included here for comparison only.
kb) was increased to nearly the same extent in all the psoriatic samples (Fig 2, middle panel) .
As previously reported [14) , low levels of IL-l p mRNA are detectable by Northern blotting in some but not all psoriatic lesions (Fig 3) . In pretreatment specimens in wh.ich IL-8 mRNA I~ve ls
Were increased, IL-l p mRN A tended to be 111creased as well (Fig 3) .
The autoradiographic data from the 12 subjects shown in Fig 3 and from an additional 14 subjects not shown were quantitated by densitometry or phosphorimager and normalized to cyclophilin. As expected on the basis of inspection of the blots shown in Fig 3, pretreatment IL-l P and IL-8 mRNA levels were highly correlated (r = 0.86, P < 0.0001, Fig 4) . m~NA levels were markedly reduced after 1 week of CsA therapy (Fig 3, second pa~lel from top) . IL-l p mRNA levels appeared to be reduced ~y CsA.1I1 a coordinate fas hion (Fig 3, third panel from top) .
~ome patients displayed a reduction in the intensity of the cyclophi-1111 control gene after 1 week of CsA therapy. This appeared to be du~ ~o red~ced RNA 1I1tac tness, as detected by ethidium bromide sta1l1111g (Fig 3, top panel) . This overall decrease in RNA intactness after ~sA was. reflec~ed in similar red uctions in a separate control gene, hpocort1l1 2 (Fig 3, bottom panel) . These variations were controlled for b~ normalizing the quantitative data to cyclophilin. Even after normahzatlon, marked and sign.ificant reductions in both IL-8 (81.2%, p < 0.02 by two-sided paired t test) and IL-l p (85 .8%, P < 0.015) mRNA levels were observed (Fig 5) . In contrast, only a shght decrease 111 CRABP-II mRNA was observed (8.7%, p = 0.05).
Correlation ofIL-tp mRNA and Protein Levels To assess the relationship between cytokine mRNA and protein levels IL-l ll'
and ~ protein levels were measured by ELISA. IL-l fJ mR'NA and protell1levels measured pnor to CsA treatment were highly corre- IL-t a protein was detectable, and pretreatment IL-l a and P protein levels also proved to be correlated (r = 0.52, P < 0.05, n = 15).
However, CsA treatment had no effect on IL-l a protein levels, whereas IL-l P protein, like IL-t P mRNA, was significantly reduced after 1 week (p < 0.004, Fig 6) .
CsA Effects on Cytokine Expression in Cultured Keratinocytes Figure 7 shows results representative of 12 experiments in which secondary cultures of normal human keratinocytes were propagated in serum-free KGM, pretreated either with CsA, TAC, or vehicle control, then subjected to treatments with various cytokines. CsA at doses up to 10 11M (12,000 ngjml) and TAC at doses up to 111M (300 ng/ml) were completely ineffective in inhibiting the induction of IL-8 mRNA in response to IL-t a or IFN-y plus TNF-a (Fig 7, and additional experiments not shown). Variation of 'the time of CsA pretreatment from 2-24 h had no effect on the results (data not shown). As previously reported [20] [21] [22] , ICAM-l mRNA was induced markedly by IFN-y plus TNF in keratinocytes grown in KGM. However, pretreatment with either CsA or TAC also had no effect on these responses (Fig 7) . IL-l treatment at 100 U jml produced only a low and variable ICAM-! mRNA response, which appeared to be potentiated slightly by CsA (Fig 7 and data not shown}. In additional experiments designed to vary the state of keratinocyte differentiation, cells were cultured in 2 mM CaCI 2 for one passage or allowed to grow to postconfluence prior to CsA pretreatment and cytokine challenge. However, neither of these maneuvers had any effect on the results (data not shown). The lack of effect of T AC was not due to the presence of hydrocortisone in KGM, as its exclusion from the medium for one passage prior to assay had no effect on the results (data not shown).
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In contrast to its lack of effect on keratinocytes, the same CsA preparation potently inhibited the two-way AMLR with an IC so of approximately 20 ngjml (Fig 8A) . Similarly, TAC inhibited the AMLR with an lC so of < 1 nM ( < 0_3 ngjml) (Fig 8B) . Both agents gave nearly complete inhibition of the AMLR at concentrations that were ineffective for inhibition of keratil10cyte responses (compare Figs 7 and 8 ) .
DISCUSSION
The strong association of psoriasis with certain HLA types [23] , as well as the effectiveness of several anti psoriatic therapies that share immunosuppression as a common feature (e.g., CsA, corticosteroids, methotrexate, UVB, and PUV A [1,24 -26] ), clearly implicate abnormalities of the immune system in the pathogenesis of psoriasis. CsA and corticosteroids have relatively little effect on keratinocyte proliferation in vitro at clinically relevant doses [5,6,10]' sug· gesting that psoriatic epidermal hyperplasia is not autonomous but rather a response to immune system activation. This concept raises the question of whether the keratinocyte is merely an "innocent bystander," or in fact plays an active role in the initiation and/or maintenance of the psoriatic lesion.
Keratinocytes may participate in the pathogenesis of psoriasis through the generation of chemotactic signals for immune/inflammatory cells [6, 8] . IL-8 is one candidate for such a signal, as it is known to be chemotactic for neutrophils ill vivo [27, 28] and for lymphocytes ill vitro [29] , and IL-8 RNA and protein are increased in psoriatic lesions ([. 30 -32] , . Fig 2) . I.L-.8 is ~ member of.the int~rcrine a family of cytokmes, wluch are dlstmgUlshed by their localIzation on chromosome 4q21 [33, 34] . These cytokines are often considered as secondary response elements of the cytokine cascade, because several of them share the property of inducibility by other (primary) cytokines (namely IL-1 and TNF-a) in a variety of cell types [33, 34] . IL-8 also has the properties of a secondary cytokine in cultured keratinocytes, as its expression is induced by IL-1 [21] or by TNF-C\' acting in concert with IFN-y [20] .
. In studying the effect of CsA on epidermal cytokine expression in psoriasis lesions, we analyzed keratome biopsies after 1 week of therapy, when no significant improvement in clinical status could be detected. This time interval was selected to avoid the confounding effect of overall reduction in lesion severity on the results. In this study, IL-8 and IL-1 p were variably but coordinately expresse~ in pretreatment biopsies (Fig 3) , resulting in a significant correlatIOn between pretreatment IL-1 p and IL-8 mRNA levels (Fig 4) .
Curiously, neither differences in clinical status nor in the total number of bone marrow-derived inflammatory cells in the lesions could explain the observed variability in cytokine mRNA levels. After 1 week, both cytokine transcripts were markedly reduced (81-85%), whereas CRABP-II transcripts were reduced only slightly (8%) ( sponse is variable in space and/or time and is therefor~ not always detec ted. We favor the latter explanation, because the differences 111 pretreatment cytokine mRNA levels between patients could n~t be accounted for in terms of the total numbers of bone marrow-denved cells in the biopsy specimen. In further support of this concept, one of four placebo-treated patients showed a large increase in IL-8 and IL-l p mRNA between week 0 and week 1 (data not shown).
Given the relative specificity of CsA for T cells [2] , the simplest explanation for these resul ts is that CsA inhibits the ability of activated T cells to produce signals leading to increased keratinocyte cytokine expression, but does not directly inhibit the ability ofkeratinocy tes to respond to such signals. To test this hypothesis, we studied the effects of CsA on IL-8 expression by cytokine-stimulated cultured keratinocytes. We focused on IL-8, rather than IL-l p, because the high levels ofIL-8 detectable in some lesions indicate that the bulk of the IL-8 expression in psoriatic lesions is occurring in keratinocytes. Although IL-8 can be expressed in a variety of cell types found in the skin, including T cells [35] , macrophages [3~] , and fibroblasts [21] , its expression at high levels by keratinocytes 111 psoriasis has been convincingly demonstrated [32] . In contrast, IL-1 p mRN A levels in psoriatic lesions are near the lo.wer limi~ of de tecrability of the Northern blot assay [14] , which IS approximately 1 copy per cell under the conditions used [37] . Thus, it is unclear whether the IL-1 p mRNA detected by Northern blotting in psoriasis lesions is keratinocyte derived. CsA was unable to inhibit cytokine-stimulated IL-8 expression in cultured keratinocytes after either CsA or TAC treatment, at concentrations far higher than those required to inhibit the l1~ixed lymphocyte response (Figs 7, 8) .. This result strongly reinforces the conclUSIOn that the keratmocyte IS not the direct target of CsA action in psoriasis. The inactivity of CsA in this regard was not limited to the IL-8 response, as the ICAM-1 mRNA response to IFN-y plus TNF-a was unaffected, and the limited ICAM-1 response to IL-l was slightly potentiated (Fig 7) .
CSA INHIBITS EPIDERMAL CYTOKINES 765
These results are consistent with previous studies that show that at concentrations as high as 1-5 ,ug/ml, CsA does not inhibit, and in fact may slightly potentiate, keratinocyte expression oOL-I, GM-CSF, IP-10, and transforming growth factor (TGF)-a [38, 39] .
Regardmg the nature of the T-cell-derived signal(s), we speculate that limited expression of primary cytokine(s) either directly by T cells or by infiltrating macrophages and/or dendritic cells under the control of T cells might trigger the expression of IL-8 at much high.er levels. in nearby keratinocytes. This interpretation would be consl~tent With. the demons~ratlOn of clusters of IL-8 -expressing kerat1110cytes directly overlymg collections of leukocytes [32] . It is attractive to speculate that one of these primary cytokines might be IL-1 P; however, our previous studies of IL-l in psoriasis indicated that IL-l P extracted from psoriatic lesions lacked biologic activity [14] . Among many other possibilities, T -cell-derived IL-8 itself could be one of the signals linking T cells and keratinocytes. Thus, CsA ha~ been ~hown to inhibit the expression of IL-8 and several related Intercnne-a gene family members in T lymphocytes [35] but not In lfolonocytes [35, 36] . Alternatively, the rel evant signal for the productIOn of IL-8 in keratinocytes could be actual contact with T cells or macrophages themselves [40] . Preliminary reports have suggested that IL-8 can stimulate keratinocyte growth in organotypIC ~ulture systems,' and limited effects of IL-8 on keratinocyte proltferatlOn have been observed under serum-free conditions [41] . ~hether IL-~ and related cytokines such as gro-at directly contnbute to psonatlc epidermal hyperplasia in villa remains to be determined.
.The strong positive correlation between IL-1 P mRNA and protem levels before and after CsA therapy indicates that the low level of expressIOn detectable by Northern blotting is reflective of the a~ount o~IL~ 1 P actually present in psoriatic lesions. However, the biologiC slgmficance of these observations remains obscure, and review of the I~terature reveals many apparent inconsistencies in the le~els of cytokme mRNAs, proteins, and biologic activities in psoriatic leSIOns [14,~2,36,42-45] . Potential explanations for these disparate observations include: i) translation of unstable or rare mRNAs mto stable proteins; ii) antibody cross-reactions with other keratinocyte proteins; iii) differential biologic activities of intra-and extr~cellul~ ~ytokine pools; iv) the presence of specific and nonspeCific mhlbltory pr<:>teins; and v) the uptake of cytokines syntheSized elsewhere by epidermal keratinocytes. Experimental evidence suppo.rts th.e conc.ept that the skin may serve as a depot for systemic cytokmes, mcludmg TNF-a [46] and IL-6 [47] . Moreover, proteins as large as bov111e serum albumin (molecular weight 69,000) can enter the epldermal .compartment from the circulation [48] . Additional careful investigations will be required to fully elucidate the cellular source(s) of epidermal cytokines ill villa.
T aken together with results demonstrating the coordinate variability ~n all three forms of MGSA/ gro in psoriatic lesions and their :eductlOn after 1 ",:,eek of CsA treatment, t the results presented here ll1dlcate that multiple keratmocyte-derived cytokines are under coordinate regulation in psorias is. perhaps by virtue of a shared signal transduction pathway.capable of responding to T-cell-derived signals. The reduction m ~L-8/gro chemotactic activity after CsA treatme. nt would beyredlcted to suppress further influx ofT cells and antlgen-presentmg cells [6, 8] , contributing to eventual resolution of the lesion. However. substantial clinical resolution required 6-8 weeks of therapy (Fig 1) , whereas cytokine expression levels were mar~edly reduced afte~ only 1 week (Figs 3, 5) . It is possible that once 111ltlated, the keratll10cyte may be capable of sustaining a hyperproiIferauve response via CsA-insensitive autocrine mechanisms, such as overexpression of the EGF-like growth factors TGF-a and amphiregulin [49] [50] [51] [52] . In any case, these results strongly support the concept that esA acts rapidly but indirectly ~o reduce expression of IL-8 and IL-l P expressIOn by th.e ps~natlc keratinocyte in lIillo, and suggest a role for these cytokmes m the pathogenesis of psoriasis.
